Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients

Detalhes bibliográficos
Autor(a) principal: OLIVEIRA,Miriam da Costa
Data de Publicação: 2020
Outros Autores: BAREA,Liselotte Menke, HORN,Andreia Peres Klein, ONGARATTI,Bárbara Roberta, SOARES,José Otávio Dworzeki, ARAUJO,Bruna, SANTOS,Tainá Mafalda dos, RECH,Carolina Leães, PEREIRA-LIMA,Júlia Fernanda Semmelmann
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028
Resumo: Abstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain.
id ABNEURO-1_25c8d7ca961aa5040be5f8b1a1fff1aa
oai_identifier_str oai:scielo:S0004-282X2020000100028
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Resolution of headache after reduction of prolactin levels in hyperprolactinemic patientsheadachepituitary adenomasprolactinhyperprolactinemiadopaminergic agonistAbstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain.Academia Brasileira de Neurologia - ABNEURO2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028Arquivos de Neuro-Psiquiatria v.78 n.1 2020reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282x20190143info:eu-repo/semantics/openAccessOLIVEIRA,Miriam da CostaBAREA,Liselotte MenkeHORN,Andreia Peres KleinONGARATTI,Bárbara RobertaSOARES,José Otávio DworzekiARAUJO,BrunaSANTOS,Tainá Mafalda dosRECH,Carolina LeãesPEREIRA-LIMA,Júlia Fernanda Semmelmanneng2020-02-11T00:00:00Zoai:scielo:S0004-282X2020000100028Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2020-02-11T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
title Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
spellingShingle Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
OLIVEIRA,Miriam da Costa
headache
pituitary adenomas
prolactin
hyperprolactinemia
dopaminergic agonist
title_short Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
title_full Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
title_fullStr Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
title_full_unstemmed Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
title_sort Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
author OLIVEIRA,Miriam da Costa
author_facet OLIVEIRA,Miriam da Costa
BAREA,Liselotte Menke
HORN,Andreia Peres Klein
ONGARATTI,Bárbara Roberta
SOARES,José Otávio Dworzeki
ARAUJO,Bruna
SANTOS,Tainá Mafalda dos
RECH,Carolina Leães
PEREIRA-LIMA,Júlia Fernanda Semmelmann
author_role author
author2 BAREA,Liselotte Menke
HORN,Andreia Peres Klein
ONGARATTI,Bárbara Roberta
SOARES,José Otávio Dworzeki
ARAUJO,Bruna
SANTOS,Tainá Mafalda dos
RECH,Carolina Leães
PEREIRA-LIMA,Júlia Fernanda Semmelmann
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv OLIVEIRA,Miriam da Costa
BAREA,Liselotte Menke
HORN,Andreia Peres Klein
ONGARATTI,Bárbara Roberta
SOARES,José Otávio Dworzeki
ARAUJO,Bruna
SANTOS,Tainá Mafalda dos
RECH,Carolina Leães
PEREIRA-LIMA,Júlia Fernanda Semmelmann
dc.subject.por.fl_str_mv headache
pituitary adenomas
prolactin
hyperprolactinemia
dopaminergic agonist
topic headache
pituitary adenomas
prolactin
hyperprolactinemia
dopaminergic agonist
description Abstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain.
publishDate 2020
dc.date.none.fl_str_mv 2020-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0004-282x20190143
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.78 n.1 2020
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212785934303232